Industry Innovation and Collaboration in the Greater Bay Area: Biomedicine and Smart Healthcare
Theatre 2, Level 1, Hong Kong Convention and Exhibition
Putonghua, Cantonese (No simultaneous interpretation service provided)
Under the Outline Development Plan for the Guangdong-Hong Kong-Macao Greater Bay Area promulgated in February 2019, the Greater Bay Area is positioned to continue deepening reform and further opening up for better integration with the global market system. The environment for innovation in the Greater Bay Area will be enhanced, including those for research and development of biomedicine, high-end medical diagnosis and treatment equipment, genetic testing, modern Chinese medicine, etc. The Department of Commerce of Guangdong Province and the Hong Kong Trade Development Council are jointly organising a seminar entitled Industry Innovation and Collaboration in the Greater Bay Area: Biomedicine and Smart Healthcare. Representatives from bio-medical sector will share their experiences and views on the prospects of cooperation with industry players in the Greater Bay Area.
Health Commission of Guangdong Province
Mr. Wing Chu
Business Advisory Manager, Research Department, HKTDC
Infinite Capital Holding Company
Mr. Simon Sze
Associate Director, BioMedical Technology Cluster, Hong Kong Science & Technology Park
Professor Sun Dongmei
Technical Director, Guangdong Yifang Pharmaceutical Co., Ltd.
Ms. Xin Rong
Deputy General Manager, Guangdong Sunho Pharmaceutical Co., Ltd.